Does levodopa improve vision in albinism? Results of a randomized, controlled clinical trial - Summers, C Gail; Connett, John E; Holleschau, Ann M; Anderson, Jennifer L; De Becker, Inge; McKay, Brian S; Brilliant, Murray H (Clinical & experimental ophthalmology, 2014)
Keywords: Administration, Oral; Adolescent; Adult; Albinism; Albinism, Oculocutaneous - drug therapy; Albinism, Oculocutaneous - genetics; Albinism, Oculocutaneous - physiopathology; Child; Child, Preschool; Clinical trials; Dopamine; Dopamine Agents - adverse effects; Dopamine Agents - therapeutic use; Double-Blind Method; Female; Humans; levodopa; Levodopa - adverse effects; Levodopa - therapeutic use; Male; Middle Aged; Neural networks; Prospective Studies; randomized controlled trial; visual acuity; Visual Acuity - drug effects; Visual Acuity - physiology; visual acuity; levodopa; albinism; randomized controlled trial